On this page
What Does “Enlarged Prostate” Mean?
When people talk about an “enlarged prostate”, they are almost always referring to benign prostatic hyperplasia (BPH). This is a progressive, non-cancerous enlargement of the prostate gland, which is the walnut-sized organ responsible for producing the fluid component of semen.
Anatomy: Why Size Matters
The prostate sits just below the bladder and surrounds the urethra, the tube that carries urine from the bladder through the penis and out of the body. This anatomical relationship is the key to understanding why an enlarged prostate causes urinary problems: as the gland grows, it compresses the urethral channel from the outside, much like placing a foot on a garden hose. Even modest compression can significantly restrict urine flow.
Who Is Affected?
The exact causes of BPH remain incompletely understood, but age is the most firmly established risk factor. The condition is rare before age 40 but becomes increasingly prevalent after that age. It affects approximately:
- 50% of men in their 50s
- 70% of men in their 70s
- 90% of men in their 80s
Hormonal factors, particularly lifelong exposure to dihydrotestosterone (DHT), play a key role in prostate growth throughout a man’s life. DHT is a potent androgen derived from testosterone.
An Important Nuance
Prostate volume and symptom severity are not linearly correlated. Some men with significantly enlarged prostates have minimal or no urinary symptoms, while others experience severe urinary obstruction despite only modest gland enlargement. This variability depends on the specific anatomical relationship between the enlarged tissue and the urethra, as well as individual differences in urinary tract sensitivity and bladder function.
Sexual Symptoms of BPH
The most commonly recognized symptoms of BPH are urinary in nature: weak stream, hesitancy, straining to urinate, incomplete bladder emptying, urinary urgency, frequent daytime urination, and nocturia (waking repeatedly at night to urinate).
But what about sexual function? This is where the picture becomes more nuanced, and it is often misunderstood.
Post-Ejaculatory Pain
One genuinely disease-related sexual symptom is pain or discomfort following ejaculation, which some men with BPH experience. This is thought to reflect prostatic inflammation or congestion that can accompany the enlarged gland.
The Broader Sexual Impact: Disease or Treatment?
Here lies a critical distinction that is frequently overlooked: the majority of so-called “sexual symptoms” attributed to BPH are not caused by the disease itself. Instead, they are primarily side effects of the treatments used to manage it.
That said, some authors suggest that men with more severe urinary symptoms develop, with greater frequency:
- Reduced sexual desire (libido)
- Greater difficulty achieving and maintaining erections (erectile dysfunction)
- Premature ejaculation
- Overall reduction in sexual satisfaction
The Indirect Mechanisms
Whether BPH directly causes sexual dysfunction, or if the relationship is indirect and multifactorial, remains an active area of research. Several plausible indirect mechanisms have been proposed:
-
Sleep disturbance: nocturia forces men to wake repeatedly throughout the night, causing sleep fragmentation and chronic fatigue. Sleep deprivation significantly reduces testosterone production, libido, and erectile function independently of any direct prostatic effect.
-
Anxiety and psychological stress: the anxiety of experiencing urinary urgency and frequency, particularly the fear of incontinence during sexual activity, creates performance anxiety and emotional inhibition. This, in turn, profoundly affects sexual desire and response.
-
Shared underlying risk factors: BPH and erectile dysfunction share common modifiable risk factors. These include cardiovascular disease, diabetes, obesity, smoking, and a sedentary lifestyle. Because of these overlapping factors, it is difficult to establish a direct causal link between the two conditions.
-
Pelvic floor and vascular factors: chronic pelvic congestion, altered pelvic blood flow, and pelvic floor tension associated with BPH may contribute to erection quality through vascular mechanisms.
The current scientific consensus is that both direct and indirect mechanisms likely operate simultaneously, and their relative contribution varies between individuals.
BPH Treatment: Solution or Additional Problem?
This is where the clinical picture becomes particularly complex, making patient counseling before initiating therapy essential.
Many of the most commonly prescribed treatments for BPH carry significant risks of sexual side effects, which can themselves be a major source of distress and reduced quality of life for patients.
Pharmacological Side Effects
The two main drug classes used for BPH have distinct sexual side effect profiles:
Alpha-Blockers (e.g., tamsulosin, alfuzosin, silodosin)
These drugs relax the smooth muscle of the prostate and bladder neck, improving urinary flow. However, they can cause:
- Retrograde ejaculation: particularly with silodosin, semen is propelled backward into the bladder at orgasm instead of being expelled through the urethra. This leads to a “dry orgasm”. It is important to note that retrograde ejaculation does not physically diminish the pleasure of orgasm; the sensation remains intact. However, for many men, the psychological impact (the absence of visible ejaculate) is significant and can cause considerable distress. It also has obvious implications for fertility.
- Reduced ejaculate volume
- Some reduction in libido in a subset of patients
5-Alpha Reductase Inhibitors (5-ARIs) (e.g., finasteride, dutasteride)
These medications block the conversion of testosterone to DHT, actually reducing prostate volume over time. They are highly effective for larger prostates and significantly reduce the risk of urinary retention and the need for surgery. However, their sexual side effects are particularly well-documented and can be persistent:
- Reduced libido (decreased sexual desire)
- Erectile dysfunction: difficulty achieving or maintaining erections
- Ejaculatory disorders: reduced ejaculate volume
- Reduced fertility: decreased sperm quality and motility
- Post-finasteride syndrome (controversial but increasingly recognized): a subset of men report persistent sexual and cognitive side effects even after discontinuing the medication. This remains an active area of investigation and regulatory scrutiny
Surgical Side Effects
Surgical interventions for BPH, most commonly transurethral resection of the prostate (TURP) or, increasingly, laser prostatectomy (HoLEP, GreenLight), are highly effective at relieving urinary obstruction. However, these procedures carry their own sexual risks.
- Retrograde ejaculation: the most common sexual consequence of BPH surgery, affecting 65–90% of men following TURP. As with medication-induced retrograde ejaculation, physical pleasure is not diminished. However, the psychological impact and effect on fertility can be significant.
- Erectile dysfunction: affects a minority of men after surgery (estimates vary by procedure type and patient baseline), most commonly due to inadvertent injury to the autonomic nerve fibers that run adjacent to the prostate and are responsible for triggering erection. Modern surgical techniques aim to minimize this risk.
- Urinary incontinence: typically temporary, though in rare cases it may become permanent, particularly stress incontinence.
The Essential Pre-Treatment Discussion
These potential consequences underscore the critical importance of a thorough informed consent conversation before initiating any BPH treatment. Men should be fully informed of both the expected benefits and the sexual side effects of each option. This way, they can make decisions that align with their values and priorities, especially when it comes to fertility and sexual function.
So, What Should Men Do?
The evidence points toward a clear, evidence-based strategy: early detection, timely treatment, and proactive lifestyle management.
1. Don’t Delay Diagnosis
The most important message is this: seek specialist evaluation from a urologist at the first signs of urinary symptoms, instead of waiting for the condition to worsen. Early-stage BPH can often be managed with:
- Natural remedies and supplements (for example, serenoa repens or saw palmetto; evidence is modest, but the side effect profile is favorable)
- Lower medication doses, which come with a reduced risk of side effects
- Watchful waiting with active monitoring: appropriate for mild, non-bothersome symptoms
- Targeted dietary modifications
Early diagnosis maximizes the opportunity to use the least invasive options before significant obstruction develops.
2. Optimizing Lifestyle: The Overlooked Intervention
It is essential to recognize that not all men treated for BPH develop sexual side effects, and in many cases, erectile dysfunction and reduced libido are at least partly due to lifestyle factors rather than the disease or its treatment.
Modifiable lifestyle factors that independently impair sexual function include:
- Smoking: vascular damage reduces penile blood flow essential for erection
- Overweight and obesity: excess adipose tissue converts testosterone to estrogen, reducing testosterone levels and sexual drive
- Poor diet (high in processed foods, saturated fat, and refined sugars): promotes vascular and metabolic dysfunction that affects erectile physiology
- Physical inactivity: regular aerobic exercise is one of the most potent natural enhancers of testosterone levels, erectile function, and cardiovascular health
This means that adopting an active lifestyle with a healthy diet and effective stress management can have a profound positive impact on sexual quality of life, independently of BPH management, and may partially counteract any treatment-related sexual side effects.
3. Emerging Pharmacological Solutions
A particularly promising development in BPH management is the recognition that phosphodiesterase type 5 (PDE5) inhibitors, the drug class that includes sildenafil (Viagra), tadalafil (Cialis), and vardenafil, have demonstrated beneficial effects on both urinary symptoms and erectile function in men with BPH.
Tadalafil, in particular, is now FDA and EMA approved for the treatment of BPH-related lower urinary tract symptoms (LUTS), either alone or in combination with other BPH medications. This dual benefit makes it an attractive option for men in whom sexual function is a priority and who have concomitant erectile concerns.
This evolving therapeutic landscape means that today there are options capable of adequately controlling prostate symptoms without compromising, and potentially even improving, sexual function.
4. Open Communication with Your Urologist
Men should feel encouraged to openly discuss sexual concerns with their urologist before, during, and after BPH treatment. Sexual health is a legitimate and important dimension of overall wellbeing, and modern urology recognizes this. Treatment plans can often be tailored to minimize sexual side effects while maintaining adequate urological control.
Sources and Bibliography
- Harvard Medical School: Sex and the Prostate: Overcoming Erectile Dysfunction When You Have Prostate Disease
- Healthline: Enlarged Prostate and Sexual Function
- Rosen R, et al. Lower Urinary Tract Symptoms and Sexual Health: The Role of Gender, Comorbidities, and Patient Perspective. BJU Int. 2003. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473005/
- Oelke M, et al. EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms. European Association of Urology (EAU). 2022. https://uroweb.org/guidelines/treatment-of-non-neurogenic-male-luts
- McVary KT, et al. Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia. J Urol. 2011. https://doi.org/10.1016/j.juro.2011.01.074
- Gacci M, et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol. 2012. https://doi.org/10.1016/j.eururo.2012.04.033
- Mayo Clinic: Benign Prostatic Hyperplasia (BPH)
- NHS: Benign Prostate Enlargement
